Clusterin (apoJ) Alters the Aggregation of Amyloid β-Peptide (Aβ1-42) and Forms Slowly Sedimenting Aβ Complexes That Cause Oxidative Stress

Amyloids: The History of Toxicity and Functionality

Yakupova, E. I., Bobyleva, L. G., Shumeyko, S. A., Vikhlyantsev, I. M., & Bobylev, A. G. (2021) · Biology · doi:10.3390/biology10050394 · Cited by 34

Apolipoproteins J and E co-localise with amyloid in gelatinous drop-like and lattice type I corneal dystrophies

Nishida, K., Quantock, A. J., Dota, A., Choi-Miura, N.-H., & Kinoshita, S. (1999) · British Journal of Ophthalmology · doi:10.1136/bjo.83.10.1178 · Cited by 33

Normal levels of clusterin in cerebrospinal fluid in Alzheimer's disease, and no change after acute ischemic stroke

Lidström, A.-M., Hesse, C., Rosengren, L., Fredman, P., Davidsson, P., & Blennow, K. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3501 · Cited by 32

Structural Interaction of Apolipoprotein A-I Mimetic Peptide with Amyloid-β Generates Toxic Hetero-oligomers

Sahoo, B. R., Bekier, M. E., Liu, Z., Kocman, V., Stoddard, A. K., Anantharamaiah, G. M., Nowick, J. S., Fierke, C. A., Wang, Y., & Ramamoorthy, A. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.005 · Cited by 30

Astrocytic response mediated by the CLU risk allele inhibits OPC proliferation and myelination in a human iPSC model

Liu, Z., Chao, J., Wang, C., Sun, G., Roeth, D., Liu, W., Chen, X., Li, L., Tian, E., Feng, L., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112841 · Cited by 30

In Vitro Amyloid Aggregate Forming Ability of TGFBI Mutants that Cause Corneal Dystrophies

Yam, G. H., Wang, R. C., Jhanji, V., Choy, K. W., Baum, L., & Pang, C. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-9068 · Cited by 31

Targeting Generation of Antibodies Specific to Conformational Epitopes of Amyloid β-Derived Neurotoxins

Lambert, M., Velasco, P., Viola, K., & Klein, W. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709787601876 · Cited by 29

Prion protein oligomer and its neurotoxicity

Huang, P., Lian, F., Wen, Y., Guo, C., & Lin, D. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt037 · Cited by 29

Extracellular Chaperones

Dabbs, R. A., Wyatt, A. R., Yerbury, J. J., Ecroyd, H. W., & Wilson, M. R. (2011) · Topics in current chemistry · doi:10.1007/128_2011_262 · Cited by 28

[33] Analysis of amyloid-β assemblies using tapping mode atomic force microscopy under ambient conditions

Ding, T. T., & Harper, J. D. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)09035-7 · Cited by 28

Clusterin mRNA and Protein in Alzheimer's Disease

Baig, S., Palmer, L. E., Owen, M. J., Williams, J. H., Kehoe, P. G., & Love, S. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110473 · Cited by 28

Transcriptomic Changes Related to Cellular Processes with Particular Emphasis on Cell Activation in Lysosomal Storage Diseases from the Group of Mucopolysaccharidoses

Rintz, E., Gaffke, L., Podlacha, M., Brokowska, J., Cyske, Z., Węgrzyn, G., & Pierzynowska, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093194 · Cited by 27

Clusterin is a Potential Therapeutic Target in Alzheimer’s Disease

Palihati, N., Tang, Y., Yin, Y., Yu, D., Liu, G., Quan, Z., Ni, J., Yan, Y., & Qing, H. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03801-1 · Cited by 25

The Association Between Clusterin and APOE Polymorphisms and Late-Onset Alzheimer Disease in a Turkish Cohort

Alaylıoğlu, M., Gezen‐Ak, D., Dursun, E., Bılgıç, B., Hanagasi, H. A., Ertan, T., Gurvit, H. I., Emre, M., Eker, E., Uysal, Ö., et al. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716640373 · Cited by 25

Deciphering pathogenicity of variants of uncertain significance with CRISPR-edited iPSCs

Guo, H., Liu, L., Nishiga, M., Cong, L., & Wu, J. C. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.08.009 · Cited by 32

The Ins and Outs of Clusterin: Its Role in Cancer, Eye Diseases and Wound Healing

Gross, C., Guérin, L.-P., Socol, B. G., Germain, L., & Guérin, S. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713182 · Cited by 25

Inhibition of Aβ fibril formation and Aβ-induced cytotoxicity by senile plaque-associated proteins

Monji, A., Yoshida, I., Tashiro, K., Hayashi, Y., Matsuda, K., & Tashiro, N. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00899-x · Cited by 24

Relevance of N-terminal residues for amyloid-β binding to platelet integrin α IIb β 3 , integrin outside-in signaling and amyloid-β fibril formation

Donner, L., Gremer, L., Ziehm, T., Gertzen, C. G. W., Gohlke, H., Willbold, D., & Elvers, M. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.06.015 · Cited by 22

Laminin inhibits both Aβ40 and Aβ42 fibril formation but does not affect Aβ40 or Aβ42-induced cytotoxicity in PC12 cells

Monji, A., Tashiro, K., Yoshida, I., Kaname, H., Hayashi, Y., Matsuda, K., & Tashiro, N. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00273-6 · Cited by 23

Molecules that Disrupt Memory Circuits in Alzheimer’s Disease: The Attack on Synapses by Aβ Oligomers (ADDLs)

Klein, W. L., Lacor, P. N., Felice, F. G. D., & Ferreira, S. T. (2007) · Research and perspectives in neurosciences · doi:10.1007/978-3-540-45702-2_11 · Cited by 23

Expression and Purification of Chaperone-Active Recombinant Clusterin

Dabbs, R. A., & Wilson, M. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086989 · Cited by 22

Physiopathological modulators of amyloid aggregation and novel pharmacological approaches in Alzheimer's disease

DEFELICE, F. G., & Ferreira, S. T. (2002) · Anais da Academia Brasileira de Ciências · doi:10.1590/s0001-37652002000200006 · Cited by 24

Clusterin Binding Modulates the Aggregation and Neurotoxicity of Amyloid-β(1–42)

Kim, Y., Park, S., Choi, S. Y., Oh, S. B., Jung, M., Pack, C., Hwang, J. J., Tak, E., & Lee, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02973-6 · Cited by 23

Effects of the neurotrophic agent T-817MA on oligomeric amyloid-β–induced deficits in long-term potentiation in the hippocampal CA1 subfield

Takamura, Y., Ono, K., Matsumoto, J., Yamada, M., & Nishijo, H. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.037 · Cited by 21

Clusterin shortens the incubation and alters the histopathology of bovine spongiform encephalopathy in mice

Kempster, S. L., Collins, M. E., Aronow, B. J., Simmons, M. M., Green, R. B., & Edington, N. (2004) · Neuroreport · doi:10.1097/01.wnr.0000134990.97051.22 · Cited by 21

Alpha 1-antichymotrypsin interaction with A beta (1-42) does not inhibit fibril formation but attenuates the peptide toxicity.

Aksenov, M. Y., Aksenova, M. V., Jm, C., & Butterfield, D. A. (1996) · PubMed · Cited by 21

Laminin inhibits Aβ42 fibril formation in vitro

Monji, A., Tashiro, K., Yoshida, I., Hayashi, Y., & Tashiro, N. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01542-4 · Cited by 21

Inflammatory Mediators in Alzheimer’s Disease

Rogers, J., & O’Barr, S. A. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_11 · Cited by 19

Immunohistochemical characterization of novel monoclonal antibodies against the N-terminus of amyloid β-peptide

Verwey, N. A., Hoozemans, J. J. M., Korth, C., van Royen, M. R., Prikulis, I., Wouters, D., Twaalfhoven, H. A. M., van Haastert, E. S., Schenk, D., Scheltens, P., et al. (2013) · Amyloid · doi:10.3109/13506129.2013.797389 · Cited by 21

Allopregnanolone enhances the neurogenesis of midbrain dopaminergic neurons in APPswe/PSEN1 mice

Zhang, P., Xie, M. Q., Ding, Y., Liao, M., Qi, S. S., Chen, S. X., Gu, Q., Zhou, P., & Sun, C. Y. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.019 · Cited by 18

Alzheimer Disease: The Role of Aβ in the Glutamatergic System

Campos‐Peña, V., & Antônio, M. (2014) · InTech eBooks · doi:10.5772/57367 · Cited by 24

Assessing the Effects of Acute Amyloid β Oligomer Exposure in the Rat

Wong, R., Cechetto, D. F., & Whitehead, S. N. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091390 · Cited by 19

Clusterin regulates transthyretin amyloidosis

Lee, K.-W., Lee, D.-H., Son, H., Kim, Y.-S., Park, J., Roh, G. S., Kim, H. J., Kang, S.-S., Cho, G.-J., & Choi, W.-S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.166 · Cited by 17

Association of circulating markers with cognitive decline after radiation therapy for brain metastasis

Huntoon, K. M., Anderson, S. K., Ballman, K. V., Twohy, E. L., Dooley, K. E., Jiang, W., An, Y., Li, J., Roemeling, C. A. V., Qie, Y., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac262 · Cited by 18

Clusterin (APOJ) in Alzheimer’s Disease: An Old Molecule with a New Role

Woody, S. K., & Zhao, L. (2016) · InTech eBooks · doi:10.5772/64233 · Cited by 17

Aggregation of Aβ(1–42) in the presence of short peptides: conformational studies

Laczkó, I., Vass, E., Soós, K., Fülöp, L., Zarándi, M., & Penke, B. (2008) · Journal of Peptide Science · doi:10.1002/psc.990 · Cited by 17

α1-Antichymotrypsin interaction with Aβ(1–42) does not inhibit fibril formation but attenuates the peptide toxicity

Aksenov, M. Y., Aksenova, M. V., Carney, J. M., & Butterfield, D. A. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)13082-2 · Cited by 17

The Amyloid β Protein

Lazo, N. D., Maji, S. K., Fradinger, E. A., Bitan, G., & Teplow, D. B. (2005) · Wiley eBooks · doi:10.1002/9783527619344.ch17 · Cited by 18

Overview and Current Status of Alzheimer’s Disease in Bangladesh

Rahman, M. R., Tajmim, A., Ali, M., & Sharif, M. (2017) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-170012 · Cited by 21

Endogenous Human Proteins Interfering with Amyloid Formation

Gharibyan, A. L., Jayaweera, S. W., Lehmann, M., Anan, I., & Olofsson, A. (2022) · Biomolecules · doi:10.3390/biom12030446 · Cited by 17

Oxidative stress and its effect on cells functional activity of Alzheimer's disease

Dubinina, E. E., Schedrina, L. V., Незнанов, Н. Г., Zalutskaya, N. M., & Zakharchenko, D. V. (2015) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20156101057 · Cited by 16

Glioma cell activation by Alzheimer's peptide Aβ 1–42, α 1-antichymotrypsin, and their mixture

Sun, Y. X., Wright, H. T., & Janciauskiene, S. M. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/pl00012501 · Cited by 16

A reaction–diffusion model of spatial propagation of A$$\beta $$ oligomers in early stage Alzheimer’s disease

Andrade‐Restrepo, M., Ciuperca, I. S., Lemarre, P., Pujo-Menjouet, L., & Tine, L. M. (2021) · Journal of Mathematical Biology · doi:10.1007/s00285-021-01593-3 · Cited by 15

Screening for functional transcriptional and splicing regulatory variants with GenIE

Cooper, S., Schwartzentruber, J., Bello, E., Coomber, E. L., & Bassett, A. R. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa960 · Cited by 14

Amyloid β peptide promotes lysosomal degradation of clusterin via sortilin in hippocampal primary neurons

Wang, Y., Qin, X., & Paudel, H. K. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.003 · Cited by 15

Inflammatory Mechanisms of Alzheimer’s Disease

Rogers, J., & Griffin, W. S. T. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-473-3_6 · Cited by 14

Pathways to Alzheimer’s Disease: The Intersecting Roles of Clusterin and Apolipoprotein E in Amyloid-β Regulation and Neuronal Health

Laslo, A., Laslo, L., Arbănași, E. M., Ujlaki-Nagi, A.-A., Chinezu, L., Ivănescu, A. D., Arbănași, E. M., Carare, R. O., Cordoș, B. A., Popa, I. A., et al. (2024) · Pathophysiology · doi:10.3390/pathophysiology31040040 · Cited by 14

Use of Copper and Insulin-Resistance to Accelerate Cognitive Deficits and Synaptic Protein Loss in a Rat Aβ-Infusion Alzheimer's Disease Model

Begum, A. N., Yang, F., Teng, E., Hu, S., Jones, M. R., Rosario, E. R., Beech, W. K., Hudspeth, B., Ubeda, O. J., Cole, G. M., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15409 · Cited by 13

Shared effects of the clusterin gene on the default mode network among individuals at risk for Alzheimer's disease

Ye, Q., Su, F., Shu, H., Gong, L., Xie, C., Zhou, H., Zhang, Z., & Bai, F. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12682 · Cited by 13

Circadian rhythmicity of amyloid‐beta‐related molecules is disrupted in the choroid plexus of a female Alzheimer's disease mouse model

Furtado, A., Esgalhado, A. J., Duarte, A. C., Costa, A. R., Costa‐Brito, A. R., Carro, E., Ishikawa, H., Schroten, H., Schwerk, C., Gonçalves, I., et al. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25164 · Cited by 12

Hypothesis on ontogenesis and pathophysiology of Alzheimer’s disease

Schwab, E. D. P., Queiroz, R., Fiebrantz, A. K. B., Bastos, M., Bonini, J. S., & da Silva, W. C. F. N. (2022) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2022rw0170 · Cited by 13

Proteomic Analysis of Serum Proteins in Triple Transgenic Alzheimer's Disease Mice: Implications for Identifying Biomarkers for Use to Screen Potential Candidate Therapeutic Drugs for Early Alzheimer's Disease

Sui, X., Ren, X., Huang, P., Li, S., Ma, Q., Ying, M., Ni, J., Liu, J., & Yang, X. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131823 · Cited by 12

Modulators of Amyloid β-Protein (Aβ) Self-Assembly

Rahimi, F., Li, H. J., Sinha, S., & Bitan, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00006-x · Cited by 12

Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum

Tang, L., Wang, Z., Ma, L., Cao, X., Tan, L., & Tan, M. (2022) · BMC Neurology · doi:10.1186/s12883-022-03038-w · Cited by 13

Protein Chemistry of Amyloid Fibrils and Chaperones: Implications for Amyloid Formation and Disease

Yerbury, J. J., & Kumita, J. R. (2010) · Current Chemical Biology · doi:10.2174/187231310791170810 · Cited by 11

Extracellular Chaperones and Amyloids

Wilson, M. R., Yerbury, J. J., & Poon, S. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8231-3_15 · Cited by 11

Cytotoxic Intermediates in the Fibrillation Pathway: Aβ Oligomers in Alzheimer’s Disease as a Case Study

Klein, W. L. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_4 · Cited by 11

The Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI)

Elias, A. K., Wilson, M. R., Carver, J. A., & Musgrave, I. (2022) · Cells · doi:10.3390/cells11203259 · Cited by 9

β-Amyloid-induced reactive astrocytes display altered ability to support dendrite and axon growth from mouse cerebral cortical neuronsin vitro

Monnerie, H., Esquenazi, S., Shashidhara, S., & Roux, P. D. L. (2005) · Neurological Research · doi:10.1179/016164105x40020 · Cited by 10

Atorvastatin and Aβ(1–40): Not as Simple as Cholesterol Reduction in Brain and Relevance to Alzheimer Disease

Butterfield, D. A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.12.014 · Cited by 9

The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers

Mineiro, R., Albuquerque, T., Neves, A. R., Santos, C. R. A., Costa, D. R. B., & Quintela, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612541 · Cited by 10

Big versus small: The impact of aggregate size in disease

Hnath, B., Chen, J., Reynolds, J., Choi, E. S., Wang, J., Zhang, D., Sha, C. M., & Dokholyan, N. V. (2023) · Protein Science · doi:10.1002/pro.4686 · Cited by 8

The inhibitory effects of Escherichia coli maltose binding protein on β-amyloid aggregation and cytotoxicity

Sharoar, M. G., Shahnawaz, M., Islam, M. R., Ramasamy, V. S., Shin, S. Y., & Park, I. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.08.004 · Cited by 10

Clusterin Regulates the Mechanisms of Neuroinflammation and Neuronal Circuit Impairment in Alzheimer’s Disease

Yu, Y., Wang, C., Wang, B., Wang, X., Zhao, Q. S., Yan, Y., & Liu, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157271 · Cited by 9

PEGylated-nanoliposomal clusterin for amyloidogenic light chain-induced endothelial dysfunction

Guzman‐Villanueva, D., Migrino, R. Q., Truran, S., Karamanova, N., Franco, D. A., Burciu, C., Senapati, S., Nedelkov, D., Hari, P., & Weissig, V. (2017) · Journal of Liposome Research · doi:10.1080/08982104.2016.1274756 · Cited by 8

Nanomechanics of Amyloid Materials Studied by Atomic Force Microscopy

Zeng, G., Duan, Y., Besenbacher, F., & Dong, M. (2012) · InTech eBooks · doi:10.5772/36342 · Cited by 8

Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease

Ma, S. L., & LAM, L. C. W. (2011) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2011.9.2.54 · Cited by 8

Cell Line Specific Modulation of Extracellular Aβ42 by Hsp40

Carnini, A., Scott, L. O. M., Ahrendt, E., Proft, J., Winkfein, R. J., Kim, S.-W., Colicos, M. A., & Braun, J. E. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037755 · Cited by 8

Novel Susceptibility Loci for Alzheimer's DXSisease

Reitz, C. (2015) · Future Neurology · doi:10.2217/fnl.15.42 · Cited by 10

Comment on: Neurotoxicity of prion peptide 106–126 not confirmed, by Beat Kunz, Erika Sandmeier, Philipp Christen

Forloni, G., Salmona, M., Bugiani, O., & Tagliavini, F. (2000) · FEBS Letters · doi:10.1016/s0014-5793(99)01781-0 · Cited by 8

Air Pollution in Diseases of Aging

Finch, C. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813102-2.00003-0 · Cited by 7

Challenges in understanding the structure/activity relationship of Aβ oligomers

Pilkington, A. W., & Legleiter, J. A. (2019) · AIMS Biophysics · doi:10.3934/biophy.2019.1.1 · Cited by 7

Why Alzheimer’s is a Disease of Memory: Synaptic Targeting by Pathogenic Aβ Oligomers (ADDLs)

Klein, W. L., Felice, F. G. D., Lacor, P. N., Lambert, M. P., & Zhao, W.-Q. (2008) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-540-76330-7_9 · Cited by 7

The relationship between Aβ-associated free radical generation and Aβ fibril formation revealed by negative stain electron microscopy and thioflavine-T fluorometric assay

Monji, A., Utsumi, H., Yoshida, I., Hashioka, S., Tashiro, K., & Tashiro, N. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01756-6 · Cited by 7

Massive changes in gene expression and their cause(s) can be a unifying principle in the pathobiology of Alzheimer's disease

Coleman, P. D., Delvaux, E., Kordower, J. H., Boehringer, A. V., & Huseby, C. J. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14555 · Cited by 7

Serum Apo J as a potential marker of conversion from mild cognitive impairment to dementia

Romagnoli, T., Ortolani, B., Sanz, J. M., Trentini, A., Seripa, D., Nora, E. D., Capatti, E., Cervellati, C., Passaro, A., Zuliani, G., et al. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117537 · Cited by 7

The Contribution of Microscopy to the Study of Alzheimer’s Disease, Amyloid Plaques and Aβ Fibrillogenesis

Harris, J. R. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_1 · Cited by 6

Overview of Fibrillar and Oligomeric Assemblies of Amyloidogenic Proteins

Rahimi, F., & Bitan, G. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_1 · Cited by 6

The Role of Genetics in Alzheimer's Disease and Parkinson's Disease

Porter, T., Gozt, A., Mastaglia, F. L., & Laws, S. M. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch15 · Cited by 6

Photodynamic and Photothermal Therapies using Nanotechnology Approach in Alzheimer's Disease

Ozturk, B., Demir, H., Silindir‐Gunay, M., Akdağ, Y., Şahin, S., & Gülsün, T. (2025) · Current Neuropharmacology · doi:10.2174/011570159x370790250317045223 · Cited by 5

Modified Forms of LDL in Plasma

Luís, J., & Villegas, S. (2012) · InTech eBooks · doi:10.5772/25620 · Cited by 5

Computational Insights into the Development of Novel Therapeutic Strategies for Alzheimer’s Disease

Prabhakar, R. S. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.10 · Cited by 5

Alzheimer’s β-Amyloid Peptide and Free Radical Oxidative Stress

Butterfield, D. A. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46806-9_25 · Cited by 5

Lipoprotein Genes and Diet in the Evolution of Human Intelligence and Longevity

Finch, C. E., & Stanford, C. B. (2003) · Springer eBooks · doi:10.1007/978-3-642-59356-7_3 · Cited by 5

Clusterin inhibits Aβ42 aggregation through a “strawberry model” as detected by FRET‐FCS

Xu, L., Tian, S., Peng, X.-L., Hua, Y., Yang, W., Chen, L., Liu, S., Wu, W., Zhao, J., He, J., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15344 · Cited by 4

Observation of a Two-Dimensional Hydrophobic Collapse at the Surface of Water Using Heterodyne-Detected Surface Sum-Frequency Generation

Sengupta, S., Versluis, J., & Bakker, H. J. (2023) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.3c01530 · Cited by 4

Apolipoprotein ( APOA1, APOE, CLU ) genes expression in the CA3 region of the hippocampus in an ischemic model of Alzheimer's disease with survival up to 2 years

Pluta, R. M., Kocki, J., Bogucki, J., Bogucka‐Kocka, A., & Czuczwar, S. J. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241303950 · Cited by 5

Methods for Studying and Structure–Function Relationships of Non-Fibrillar Protein Assemblies in Alzheimer's Disease and Related Disorders

Bitan, F. R. A. G. (2014) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608058525114020014 · Cited by 4

Contactin 5 and Apolipoproteins Interplay in Alzheimer’s Disease

Dauar, M. T., Picard, C., Labonté, A., Breitner, J. C. S., Rosa‐Neto, P., Villeneuve, S., & Poirier, J. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231003 · Cited by 6

Methionine oxidation of clusterin in Alzheimer’s disease and its effect on clusterin’s binding to beta-amyloid

Smith, A. S., Subramanian, J., Doderer, J. J., & Moskovitz, J. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.137874 · Cited by 5

Oxidative stress and its effect on cell functional activity in Alzheimer’s disease

Dubinina, E. E., Schedrina, L. V., Незнанов, Н. Г., Zalutskaya, N. M., & Zakharchenko, D. V. (2014) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750814030044 · Cited by 4

β-amyloid-Derived Free Radical Oxidation

Butterfield, D. A., Hensley, K., Hall, N. C., Ramachandran, S., Howard, B. J., Cole, P. S., Yatin, S. M., LaFontaine, M., Harris‐White, M. E., Aksenova, M. V., et al. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_9 · Cited by 4

The Glutamatergic System in Alzheimer’s Disease Brain: Dysfunction Associated with Amyloid β-Peptide and Oxidative Stress

Butterfield, D. A. (2004) · Springer eBooks · doi:10.1007/978-1-4419-8959-8_14 · Cited by 3

The HDL-Mimetic Peptide 4F Mitigates Vascular and Cortical Amyloid Pathology and Associated Neuroinflammation in a Transgenic Mouse Model of Cerebral Amyloid Angiopathy and Alzheimer’s Disease

Zhong, R., Chernick, D., Hottman, D. A., Tan, Y., Kim, M., Narayanan, M., & Li, L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04859-9 · Cited by 4

Mechanisms of Prion Toxicity and Their Relationship to Prion Infectivity

Vella, L. J., Hill, A. F., & Cappai, R. (2005) · Springer eBooks · doi:10.1007/0-387-23923-5_9 · Cited by 3

Towards defining the Mechanisms of Alzheimer's disease based on a contextual analysis of molecular pathways

Richens, J. L., Bramble, J. P., Spencer, H. L., Cantlay, F., Butler, M., & O’Shea, P. (2016) · Global Medical Genetics · doi:10.3934/genet.2016.1.25 · Cited by 3

Beta Amyloid Protein Clearance and Microglial Activation

Frautschy, S. A., Cole, G. M., & Ard, M. D. (2002) · Springer eBooks · doi:10.1007/978-1-4757-4139-1_12 · Cited by 3

Chapter 4. Emerging themes in Alzheimer's disease research: Paradigm shift in drug discovery

Morgan, T. E., & Krafft, G. A. (2002) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(02)37005-2 · Cited by 3

Analysis of Brain Protein Stability Changes in a Mouse Model of Alzheimer’s Disease

Tang, Y., Park, H.-J., Li, S., & Fitzgerald, M. C. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00406 · Cited by 2

Clusterin Binding Modulates the Aggregation and Neurotoxicity of Amyloid-β(1–42)

Kim, Y., Park, S., Choi, S. Y., Oh, S. B., Jung, M., Pack, C., Hwang, J. J., Tak, E., & Lee, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02973-6 · Cited by 23

Relationship Between Multifunctional Protein "Clusterin" and Alzheimer Disease

Choi-Miura, N.-H., & Oda, T. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00106-6 · Cited by 54

Clusterin (Apo J) Protects Against In Vitro Amyloid‐β(1–40) Neurotoxicity

Boggs, L. N., Fuson, K. S., Baez, M., Churgay, L. M., McClure, D. B., Becker, G., & May, P. C. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67031324.x · Cited by 108

Clusterin: A forgotten player in Alzheimer's disease

Nuutinen, T., Suuronen, T., Kauppinen, A., & Salminen, A. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.05.007 · Cited by 267

Untitled work

Cole (2000) · doi:10.1002/1097-0029(20000815)50:4